Publicaties
Gekozen filters:
Gekozen filters:
MicroRNA-based diagnosis, prognosis and treatment of paediatric acute lymphoblastic leukaemia Universiteit Gent
Minimal residual disease quantification by PCR in childhood acute lymphoblastic leukaemia Universiteit Gent
Impact of minimal residual disease monitoring on therapy in Belgian childhood acute lymphoblastic leukaemia Universiteit Gent
Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials Universiteit Antwerpen Universiteit Gent KU Leuven Vrije Universiteit Brussel
Easy discrimination of hematogones from lymphoblasts in B-cell progenitor acute lymphoblastic leukemia patients using CD81/CD58 expression ratio KU Leuven
INTRODUCTION: The discrimination of leukemia lymphoblasts (LB) in diagnosis and follow-up of B-cell progenitor acute lymphoblastic leukemia (BCP-ALL) by multiparameter flow cytometry (MFC) may be difficult due to the presence of hematogones (HG). The aim of this study was to compare lymphoblasts of BCP-ALL and HG for the expression of the most discriminating antigens. METHODS: A total of 82 bone marrow samples (39 BCP-ALL and 43 patients with ...
Anti-Thymocyte Globulin Improves Survival Free From Relapse and Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Philadelphia-Negative Acute Lymphoblastic Leukemia: An Analysis by the Acute Leukemia Wo KU Leuven
BACKGROUND: Mobilized peripheral blood stem cells are currently the predominant source of grafts for allogeneic transplantation (allogeneic peripheral blood stem cell transplantation [allo-PBSCT]), although, in comparison with bone marrow, their use is associated with an increased risk of chronic graft-versus-host disease (cGVHD). Attempts to reduce the incidence of cGVHD include the addition of anti-thymocyte globulin (ATG) to the pretransplant ...